packageSotagliflozin

sotagliflozin

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Sotagliflozin is a blood glucose-lowering drug of the gliflozin class developed for type 1 diabetes. It has been investigated and, in some places, approved, but its marketing authorisation in the European Union was withdrawn, so it is not in routine use there.

Summary written by glm-5.3-flash from Wikidata Q27088840 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:sotagliflozin
ATC codes:A10BK06
DrugBank:DB12713
PubChem CID:24831714
Wikidata:Q27088840
formula:C21H25ClO5S
molar mass:424.936 g/mol (PubChem CID 24831714)
logP:3.2 (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown